English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, October 25, 2024
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'
Friday, August 30, 2024
Hua Medicine Announces 2024 Interim Results
華領醫藥公佈2024年中期業績
华领医药公布2024年中期业绩
Friday, August 25, 2023
华领医药公布2023年中期业绩
華領醫藥公佈2023年中期業績
Hua Medicine Announces 2023 Interim Results
Monday, October 10, 2022
华领医药全球首创新药葡萄糖激酶激活剂华堂宁(R)获批上市 有望拓展中国2型糖尿病治疗新格局
華領醫藥全球首創新藥葡萄糖激酶激活劑華堂寧(R)獲批上市 有望拓展中國2型糖尿病治療新格局
Hua Medicine's Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575